Anaplastic Large Cell Lymphoma — Trials

Anaplastic Large Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

183 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 14
Ph III recruiting: 3
Growth YoY: —
Industry share: 15%
Top sponsor: City of Hope Medical Center
Termination share: 26.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (33)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04021082	CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)	withdrawn	Phase 2 / Phase 3	0	Portola PharmaceuticalsINDUSTRY	0	Feb 21, 2023	clinicaltrials

Data updated 22 days agoSource updated Feb 21, 2023source: clinicaltrials